BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
search help

Documents 1-20 out of 20 found
  Current Search:  errin: 30, norethindrone: 304  

100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...

Matching: errin norethindrone Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 10/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA -A- AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA -A- AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA -A- AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA -A- AA MALLINCKRODT 750MG...
Matching: errin norethindrone Find similar documents More document info
56%
HTML
Barr Pharmaceuticals, Inc.
Contact Us Product Guide Drug Information Site Map Legal Notices Barr's web sites (the -Sites-) contain many valuable trademarks owned and/or used by Barr Pharmaceuticals, Inc.
The content, arrangement and layout of the Sites, including, but not limited to, the trademarks and text, are proprietary to Barr, and should not be copied, used, imitated, reproduced, displayed,...
Matching: errin Find similar documents More document info
56%
PDF
Pages
Barr Laboratories, Inc.
's Provigil® (Modafinil), for patients experiencing excessive daytime sleepiness associated with narcolepsy.
Expanding Our Proprietary Sales & Marketing Team As critical as new product development is, the need for an agile and efficient sales and marketing capability will be critical to realizing the value of our proprietary development activities....

author: Lisa
Matching: errin Find similar documents More document info

56%
PDF
Pages page 59


author: Lisa
Matching: errin Find similar documents More document info

56%
PDF
Pages page 14


author: Lisa
Matching: errin Find similar documents More document info

56%
DOC
South East England Regional Assembly
Joint European Committee, 22 July 2005, Meeting, Agenda Item 6 vanessaeley South East England Regional Assembly Joint European Committee, 22 July 2005, Meeting, Agenda Carl Lawton.
State of Play The JEC asked An ke Seidler in April 2005 to review the Dynamo regions network with a view to creating a more and coherent grouping of high growth regions with common concerns in order to...

Matching: Find similar documents More document info
56%
DOC
Joint Europe Committee, Meeting, September 2004
Joint Europe Committee, Meeting, September 2004, APPENDIX 2 Vanessa Eley Joint Europe Committee, Meeting, September 2004 Joint Europe Committee, Meeting, September 2004 stella bellem * o * * o * * o * Appendix 2 EUROPEAN STRATEGY REVIEW JUNE 2004 Theme Priority Green votes Red votes Top 12 Votes (Net Figure Shown) Transport Work with other prosperous regions to exchange best practice...

Matching: Find similar documents More document info
56%
HTML
T Cell Development Section, Laboratory of Cellular and Molecular Immunology, Division of Intramural Research, National
Laboratory of Cellular and Molecular Immunology T Cell Development Section B.J
Research Group Members: Chris Fleischacker, Francesca Macchiarini, Errin Matechak, Hillary Noll Awards: Roche Basic Science Award, NIH Merit Award, AAI Outstanding Investigator Award
These positive and negative selection processes both involve TCR-MHC engagement, but different aspects of these...
Matching: errin Find similar documents More document info
56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 10


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 9


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 8


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 7


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 6


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 5


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 4


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 3


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 2


Matching: errin Find similar documents More document info

56%
PDF
http://www.biomarinpharm.com/publications/Demeule_2002_High_transcytosis_of_melanotransferrin.pdf page 1


Matching: errin Find similar documents More document info

56%
PDF
http://www.eyeforpharma.com/pharma/papers/acrd.pdf page 38
Appendix communication to collaborate more closely with partners or, instead, to exploit its lobal reach to compete more a ressively. Competitive models use the Internet's ubiquitous reach to ' level the playin ield' between competitors so that, assumin everyone ...


duplicates:
http://www.pharmquest.com/corporate/Html/newsroom/articles/AC_webR&D.pdf
http://www.pharmquest.com/corporate/html/newsroom/articles/AC_webR&D.pdf
Matching: Find similar documents More document info


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.